Skip to main content
Clinical Trials/ACTRN12619001590156
ACTRN12619001590156
Recruiting
未知

Analysis of brain natriuretic peptide levels in patients with atrial fibrillation undergoing atrioventricular node ablation

Princess Alexandra Hospital0 sites30 target enrollmentNovember 19, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Princess Alexandra Hospital
Enrollment
30
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 19, 2019
End Date
TBD
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • oAge greater than or equal to 18 years
  • oPermanent atrial fibrillation
  • oLeft ventricular ejection fraction (LVEF) \>45%
  • oClinical indication for AV node ablation
  • oPermanent pacemaker already implanted or planned to be implanted prior to AV node ablation
  • oAble to provide written informed consent

Exclusion Criteria

  • oAge \< 18 years
  • oInability to provide consent
  • oLVEF \<45% or decompensated heart failure
  • oSevere valvular lesions

Outcomes

Primary Outcomes

Not specified

Similar Trials